When tested in the validation cohort , the nomograms discriminated well the high and intermediate risk from low risk patients ( hazard ratio -LSB- HR -RSB- for OS @ , @ % confidence interval -LSB- CI -RSB- @-@ @ ; and @ , @ % CI @-@ @ ; for PFS @ , @ % CI @-@ @ ; and @ , @ % CI @-@ @ , respectively ) .